
- Volume 0 0
Race Is a Factor in Receiving Treatment
Minority patients were less likely to beprescribed asthma inhalers with steroidmedication in the first 2 years after theseinhalers were introduced in the 1980s,suggested the results of a study reportedin Medical Care (January 2006). Researchersat the Massachusetts GeneralHospital Institute for Health Policy hypothesizedthat minorities may have had limitedaccess to specialists who prescribedthese new devices, as well as lack ofmoney to afford them.
For the study, the investigatorsassessed data from the NationalAmbulatory Medical Survey from 1989to 1998. They identified 3700 asthma-relatedpatient visits to physicians. Theresearchers focused on whether asthmainhalers were prescribed or usedduring those visits; they also notedinformation about the patients' age andrace/ethnicity. The findings indicatedthat, during the first 2 years, minoritypatients were 50% less likely to receiveasthma inhalers, compared with nonminoritypatients.
A shift was seen in the mid 1990sbetween minority patients and nonminoritypatients. The change, however, was areflection of increased use of asthmainhalers by African Americans. In HispanicAmericans, the low prescription rate forasthma inhalers remained unchanged.Thefindings also revealed that children wereconsiderably less likely to be prescribedinhalers, compared with adults.
Articles in this issue
almost 20 years ago
British Poll Shows People Denying Weight Problemsalmost 20 years ago
Suing a Lawyer for Malpractice?almost 20 years ago
Pharmacists—Cops or Not? (Part 1)almost 20 years ago
Can You Read These Rxs?almost 20 years ago
Alternative Measures for Treating Pediculosisalmost 20 years ago
Compounding Hotlinealmost 20 years ago
Obesity May Lead to Kidney Failurealmost 20 years ago
Body Fat Associated with Alzheimer's Proteinalmost 20 years ago
Midlife Obesity May Cause Heart Diseasealmost 20 years ago
The Evolution of Imprint IdentificationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































